Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Observational Study of the Safety and Efficacy of Intensified Chemotherapy Regimens in Aggressive B-cell Lymphomas With MYC Rearrangement

NCT07663175 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07663175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07663175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Observational Study of the Safety and Efficacy of Intensified Chemotherapy Regimens in Aggressive B-cell Lymphomas With MYC Rearrangement
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2022
Completion date
December 31, 2027
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell lymphomas with myc rearrangement